What does this research mean for the field?

Patients undergoing drug-coated balloon angioplasty for de novo coronary lesions demonstrate favorable clinical outcomes during mid-term follow-up. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To assess the clinical utility of angiography-derived fractional flow reserve (vFFR) after drug-coated balloon (DCB) angioplasty for coronary lesions.

February 26, 2026

Physiologic Assessment Using Angiography-Derived Fractional Flow Reserve After Drug-Coated Balloon Angioplasty in De Novo Coronary Lesions.

Key Result

Patients undergoing drug-coated balloon angioplasty for de novo coronary stenoses showed favorable mid-term clinical outcomes.

Key Points

To assess the clinical utility of angiography-derived fractional flow reserve (vFFR) after drug-coated balloon (DCB) angioplasty for coronary lesions.
Conducted mid-term follow-up on patients post-DCB angioplasty.
Evaluated clinical outcomes related to coronary stenoses.
Initiated discussion on the need for larger studies regarding vFFR.
Patients showed favorable clinical outcomes during follow-up.
Positive implications for the use of vFFR in assessing outcomes after DCB angioplasty.

Structured PICO

Does physiologic assessment using vFFR after DCB angioplasty impact clinical outcomes in patients with de novo coronary lesions?

Population

Patients undergoing drug-coated balloon (DCB) angioplasty for de novo coronary stenoses

Intervention

Physiologic assessment using angiography-derived fractional flow reserve (vFFR) after DCB angioplasty

Outcome

Clinical outcomes

Patients undergoing DCB angioplasty for de novo coronary lesions show favorable mid-term outcomes, but the clinical utility of post-procedure vFFR requires validation in larger studies.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Patients undergoing DCB angioplasty for de novo coronary stenoses demonstrated favorable clinical outcomes during mid-term follow-up. The clinical utility of vFFR in the context of DCB angioplasty warrants further investigation in large-scale studies to determine its impact on clinical outcomes.

Bookmark